← All stories
Markets
Why Celadon (LSE:CEL) Is in Focus After It remained a current UK medical-cannabis listing under review
Highlights Celadon Pharmaceuticals (LSE:CEL) remained a current UK medical-cannabis listing under review, adding a fresh verified development to the market record. The central analytical theme is regulated cultivation and commercial access,…
Covered by 1 outlet
All coverage · 1 article